- GRI Bio (NASDAQ:GRI) announced that the board of directors of the company approved a 1-for-13 reverse stock split of the company’s common stock.
- The Reverse Split will legally take effect at 4:01 p.m. Eastern Time, on June 17, 2024.
- The Company’s common stock will open for trading under a new CUSIP number 3622AW 304 on The Nasdaq Capital Market on June 18, 2024, on a split-adjusted basis under the current ticker symbol “GRI.”
- Source: Press Release
